Executive board | BIG against breast cancer

You are here

Executive Board

Intro text:

The Executive Board provides overall leadership for the organization, meeting several times a year to develop BIG’s scientific strategy, carry out decisions of the General Assembly, and provide oversight for the association. BIG Board members are active in the BIG member groups and may serve up to two terms of 4 years each. Half of any available seats are filled through direct election by the General Assembly and half are appointed by the Board.

David Cameron, MD

Functie:
BIG Chair

Intro:

Medical oncologist – United Kingdom

Ander Urruticoechea, MD, Phd

Functie:
Member of the executive board

Intro:

BIG Treasurer
Medical oncologist – Spain

Carlos Barrios, MD

Functie:
Member of the executive board

Intro:

Oncologist - Brazil

Philippe Bedard, MD

Functie:
Member of the executive board

Intro:

Oncologist - Canada

Judith Bliss, MSc

Functie:
Member of the executive board

Intro:

Medical Statistician & Trials Methodologist – United Kingdom

Etienne Brain, MD, Phd

Functie:
Member of the executive board

Intro:

Medical oncologist - France

Eva Carrasco, MD

Functie:
Member of the executive board

Intro:

Medical oncologist - Spain

Boon Chua, MD

Functie:
Member of the executive board

Intro:

Radiation oncologist – Australia

Read the latest interview

Barbro Linderholm, MD, Phd

Functie:
Member of the executive board

Intro:

Medical oncologist – Sweden

Sherene Loi, MD

Functie:
Member of the executive board

Intro:

Medical oncologist – Australia

Seamus O'Reilly, MD

Functie:
Member of the executive board

Intro:

Medical oncologist – Ireland

Evangelia Razis, MD

Functie:
Member of the executive board

Intro:

Medical oncologist – Greece

Shigehira Saji, MD

Functie:
Member of the executive board

Intro:

Medical oncologist – Japan

Ines Vaz-Luis, MD

Functie:
Member of the executive board

Intro:

Medical oncologist – France